221 related articles for article (PubMed ID: 22178039)
21. Evaluation of novel formulations for transarterial chemoembolization: combining elements of Lipiodol emulsions with Drug-eluting Beads.
Caine M; Chung T; Kilpatrick H; Bascal Z; Willis S; Tang Y; de Baere T; Dreher M; Lewis A
Theranostics; 2019; 9(19):5626-5641. PubMed ID: 31534507
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of biocompatibility and anti-glioma efficacy of doxorubicin and irinotecan drug-eluting bead suspensions in alginate.
Glage S; Lewis AL; Mertens P; Baltes S; Geigle P; Brinker T
Clin Transl Oncol; 2012 Jan; 14(1):50-9. PubMed ID: 22262719
[TBL] [Abstract][Full Text] [Related]
23. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.
de Baere T; Deschamps F; Teriitheau C; Rao P; Conengrapht K; Schlumberger M; Leboulleux S; Baudin E; Hechellhammer L
J Vasc Interv Radiol; 2008 Jun; 19(6):855-61. PubMed ID: 18503899
[TBL] [Abstract][Full Text] [Related]
24. Preparation and characterisation of vandetanib-eluting radiopaque beads for locoregional treatment of hepatic malignancies.
Hagan A; Phillips GJ; Macfarlane WM; Lloyd AW; Czuczman P; Lewis AL
Eur J Pharm Sci; 2017 Apr; 101():22-30. PubMed ID: 28132823
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
[TBL] [Abstract][Full Text] [Related]
26. Ethiodized oil uptake does not predict doxorubicin drug delivery after chemoembolization in VX2 liver tumors.
Gaba RC; Baumgarten S; Omene BO; van Breemen RB; Garcia KD; Larson AC; Omary RA
J Vasc Interv Radiol; 2012 Feb; 23(2):265-73. PubMed ID: 22178040
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization.
Negussie AH; Dreher MR; Johnson CG; Tang Y; Lewis AL; Storm G; Sharma KV; Wood BJ
J Mater Sci Mater Med; 2015 Jun; 26(6):198. PubMed ID: 26105830
[TBL] [Abstract][Full Text] [Related]
28. Single-center comparison of three chemoembolization regimens for hepatocellular carcinoma.
Petruzzi NJ; Frangos AJ; Fenkel JM; Herrine SK; Hann HW; Rossi S; Rosato EL; Eschelman DJ; Gonsalves CF; Brown DB
J Vasc Interv Radiol; 2013 Feb; 24(2):266-73. PubMed ID: 23261143
[TBL] [Abstract][Full Text] [Related]
29. Long-term biocompatibility, imaging appearance and tissue effects associated with delivery of a novel radiopaque embolization bead for image-guided therapy.
Sharma KV; Bascal Z; Kilpatrick H; Ashrafi K; Willis SL; Dreher MR; Lewis AL
Biomaterials; 2016 Oct; 103():293-304. PubMed ID: 27419364
[TBL] [Abstract][Full Text] [Related]
30. Effect of Transcatheter Intra-Arterial Therapies on Tumor Interstitial Fluid Pressure and Its Relation to Drug Penetration in a Rabbit Liver Tumor Model.
Liang B; Chen S; Li L; Liu Y; Xiong F; Dong X; Feng G; Gupta S; Zheng C
J Vasc Interv Radiol; 2015 Dec; 26(12):1879-86. PubMed ID: 26254117
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a novel intrinsically radiopaque Drug-eluting Bead for image-guided therapy: DC Bead LUMI™.
Ashrafi K; Tang Y; Britton H; Domenge O; Blino D; Bushby AJ; Shuturminska K; den Hartog M; Radaelli A; Negussie AH; Mikhail AS; Woods DL; Krishnasamy V; Levy EB; Wood BJ; Willis SL; Dreher MR; Lewis AL
J Control Release; 2017 Mar; 250():36-47. PubMed ID: 28188808
[TBL] [Abstract][Full Text] [Related]
32. Radiopaque and uniform alginate microspheres loaded with tantalum nanoparticles for real-time imaging during transcatheter arterial embolization.
Zeng J; Li L; Zhang H; Li J; Liu L; Zhou G; Du Q; Zheng C; Yang X
Theranostics; 2018; 8(17):4591-4600. PubMed ID: 30279724
[TBL] [Abstract][Full Text] [Related]
33. Conventional versus Drug-Eluting Bead Transarterial Chemoembolization for Neuroendocrine Tumor Liver Metastases.
Makary MS; Kapke J; Yildiz V; Pan X; Dowell JD
J Vasc Interv Radiol; 2016 Sep; 27(9):1298-1304. PubMed ID: 27499157
[TBL] [Abstract][Full Text] [Related]
34. Treatment of experimental pancreatic cancer by doxorubicin-, mitoxantrone-, and irinotecan-drug eluting beads.
Yagublu V; Caliskan N; Lewis AL; Jesenofsky R; Gasimova L; Löhr JM; Keese M
Pancreatology; 2013; 13(1):79-87. PubMed ID: 23395574
[TBL] [Abstract][Full Text] [Related]
35. Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads.
Choi JW; Cho HJ; Park JH; Baek SY; Chung JW; Kim DD; Kim HC
PLoS One; 2014; 9(12):e115898. PubMed ID: 25551760
[TBL] [Abstract][Full Text] [Related]
36. Effect of Whole-abdominal Irradiation on Penetration Depth of Doxorubicin in Normal Tissue After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in a Post-mortem Swine Model.
Khosrawipour V; Khosrawipour T; Hedayat-Pour Y; Diaz-Carballo D; Bellendorf A; Böse-Ribeiro H; Mücke R; Mohanaraja N; Adamietz IA; Fakhrian K
Anticancer Res; 2017 Apr; 37(4):1677-1680. PubMed ID: 28373428
[TBL] [Abstract][Full Text] [Related]
37. Evaluating the Effect of Micropump© Position, Internal Pressure and Doxorubicin Dosage on Efficacy of Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model.
Khosrawipour V; Khosrawipour T; Falkenstein TA; Diaz-Carballo D; Förster E; Osma A; Adamietz IA; Zieren J; Fakhrian K
Anticancer Res; 2016 Sep; 36(9):4595-600. PubMed ID: 27630300
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Clinical Efficacy and Safety between 70-150 µm and 100-300 µm Doxorubicin Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma.
Yi JW; Hong HP; Kim MS; Shin BS; Kwon HJ; Kim BI; Sohn W
Life (Basel); 2022 Feb; 12(2):. PubMed ID: 35207584
[TBL] [Abstract][Full Text] [Related]
39. Transarterial hepatic chemoembolization with 70-150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profile.
Odisio BC; Ashton A; Yan Y; Wei W; Kaseb A; Wallace MJ; Vauthey JN; Gupta S; Tam AL
J Vasc Interv Radiol; 2015 Jul; 26(7):965-71. PubMed ID: 25979305
[TBL] [Abstract][Full Text] [Related]
40. Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan.
Jordan O; Denys A; De Baere T; Boulens N; Doelker E
J Vasc Interv Radiol; 2010 Jul; 21(7):1084-90. PubMed ID: 20610183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
